Lexicon Pharmaceuticals
LXRX
#6625
Rank
โ‚น65.54 B
Marketcap
โ‚น154.70
Share price
4.38%
Change (1 day)
258.90%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -โ‚น16.40

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น17.60. In 2024 the company made an earnings per share (EPS) of -โ‚น59.29 an increase over its 2023 EPS that were of -โ‚น74.11.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น16.40-72.34%
2024-โ‚น59.29-20%
2023-โ‚น74.1131.15%
2022-โ‚น56.51-0%
2021-โ‚น56.5110.91%
2020-โ‚น50.95-145.08%
2019โ‚น113.02-206.09%
2018-โ‚น106.53-5.74%
2017-โ‚น113.02-10.95%
2016-โ‚น126.912640%
2015-โ‚น4.63-96.34%
2014-โ‚น126.41-2.53%
2013-โ‚น129.69-9.09%
2012-โ‚น142.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,646-9,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น507.65-2,984.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น3,995-22,794.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น541.00 2,973.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น583.61-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น46.32 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น69.48 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น168.60-1,057.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น7,106 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA